Delivery Order SPE2DB20D1004-SPE2DB25FNKYN
Award Date 9/23/25
Potential Completion Date 9/24/25
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for 60-tablet units of Briviact 100 mg tablets with a ceiling value of $6,386.97. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under the company's larger indefinite delivery contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Briviact 100 mg tablets (60 count) with a ceiling value of $13,237.00. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, demonstrating the contractor's capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Briviact 50 mg tablets (60-count units) under a firm fixed-price contract valued at $2,538.23. This non-set-aside competitive award is scheduled for completion by August 25, 2025, with performance to take place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,263.43 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Briviact 100 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Briviact 50 mg tablets (60-count units) with a ceiling value of $1,057.82. This firm fixed-price delivery order, which is not set-aside, represents a competitive award to support federal medical procurement needs. The contract is set to complete by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,859.98 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Briviact 50 mg tablets (60-count packages). This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement supporting federal medical supply needs. The order is scheduled for completion by August 19, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Briviact 100 mg tablets in quantities of 60 units, valued at $2,268.17. This non-set-aside, firm fixed price delivery order is scheduled for completion by August 14, 2025, with performance based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- AmerisourceBergen Drug Corp was awarded a delivery order on September 4, 2025, by the Defense Logistics Agency (DLA) for 60 tablets of Briviact 100 mg, with a contract value of $1,041.97 and an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a tactical pharmaceutical supply fulfillment under DLA's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...